{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:21:23Z","timestamp":1780561283716,"version":"3.54.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.gene.2023.147684","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T15:35:59Z","timestamp":1690904159000},"page":"147684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An integrative analysis of genotype-phenotype correlation in Charcot Marie Tooth type 2A disease with MFN2 variants: A case and systematic review"],"prefix":"10.1016","volume":"883","author":[{"given":"Yuanzhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lerong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7661-295X","authenticated-orcid":false,"given":"Hongsheng","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2023.147684_b0005","doi-asserted-by":"crossref","unstructured":"Abati, E., Manini, A., Velardo, D., et al. Clinical and genetic features of a cohort of patients with MFN2-related neuropathy. Sci. Rep. Apr 13 2022;12(1):6181. doi:10.1038\/s41598-022-10220-0.","DOI":"10.1038\/s41598-022-10220-0"},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/jhg.2011.20","article-title":"Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan","volume":"56","author":"Abe","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.gene.2023.147684_b0015","article-title":"The MFN2 V705I Variant Is Not a Disease-Causing Mutation: A Segregation Analysis in a CMT2 Family","volume":"2013","author":"Albulym","year":"2013","journal-title":"J Neurodegener Dis."},{"key":"10.1016\/j.gene.2023.147684_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12881-015-0224-8","article-title":"Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability","volume":"16","author":"Antoniadi","year":"2015","journal-title":"BMC Med. Genet."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0025","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-16-0694","article-title":"Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy","volume":"23","author":"Apellaniz-Ruiz","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/molbev\/mst217","article-title":"Conserved proteins are fragile","volume":"31","author":"Assis","year":"2014","journal-title":"Mol. Biol. Evol."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10048-013-0358-9","article-title":"Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland","volume":"14","author":"Auranen","year":"2013","journal-title":"Neurogenetics"},{"issue":"Pt 9","key":"10.1016\/j.gene.2023.147684_b0040","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/brain\/awr184","article-title":"Genetic spectrum of hereditary neuropathies with onset in the first year of life","volume":"134","author":"Baets","year":"2011","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.gene.2023.147684_b0045","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.nmd.2008.09.006","article-title":"Two Spanish families with Charcot-Marie-Tooth type 2A: clinical, electrophysiological and molecular findings","volume":"18","author":"Banchs","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"13","key":"10.1016\/j.gene.2023.147684_b0050","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.0000000000003772","article-title":"Genetic heterogeneity of motor neuropathies","volume":"88","author":"Bansagi","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.gene.2023.147684_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443706","article-title":"Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review","volume":"46","author":"Barreto","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/geno.1993.1334","article-title":"Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity","volume":"17","author":"Ben Othmane","year":"1993","journal-title":"Genomics"},{"issue":"12","key":"10.1016\/j.gene.2023.147684_b0065","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archneurol.2010.303","article-title":"Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis","volume":"67","author":"Benedetti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.gene.2023.147684_b0070","doi-asserted-by":"crossref","unstructured":"Beresewicz, M., Charzewski, L., Krzysko, K.A., Kochanski, A., Zablocka, B., 2018. Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity. Sci. Rep. Nov 15 2018;8(1):16900. doi:10.1038\/s41598-018-35133-9.","DOI":"10.1038\/s41598-018-35133-9"},{"issue":"3","key":"10.1016\/j.gene.2023.147684_b0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12017-014-8307-9","article-title":"Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease","volume":"16","author":"Bergamin","year":"2014","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.gene.2023.147684_b0080","article-title":"Genetic modifiers and non-Mendelian aspects of CMT","volume":"Jan 1 2020","author":"Bis-Brewer","year":"1726","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.gene.2023.147684_b0085","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamaneurol.2014.629","article-title":"Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features","volume":"71","author":"Bombelli","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.gene.2023.147684_b0090","doi-asserted-by":"crossref","unstructured":"Braathen, G.J., Sand, J.C., Lobato, A., Hoyer, H., Russell, M.B., 2010. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families. BMC Med. Genet. Mar 29 2010;11:48. doi:10.1186\/1471-2350-11-48.","DOI":"10.1186\/1471-2350-11-48"},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1468-1331.2010.03037.x","article-title":"Genetic epidemiology of Charcot-Marie-Tooth in the general population","volume":"18","author":"Braathen","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.gene.2023.147684_b0100","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00415-008-0847-1","article-title":"Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations","volume":"255","author":"Brockmann","year":"2008","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0105","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3892\/mmr.2013.1730","article-title":"Spectrum and frequencies of mutations in the MFN2 gene and its phenotypical expression in Czech hereditary motor and sensory neuropathy type II patients","volume":"8","author":"Brozkova","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.gene.2023.147684_b0110","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archneurol.2009.284","article-title":"Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations","volume":"66","author":"Calvo","year":"2009","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0115","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacl.2018.07.009","article-title":"MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue","volume":"12","author":"Capel","year":"2018","journal-title":"J. Clin. Lipidol. Nov-Dec"},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jns.12117","article-title":"MFN2 deletion of exons 7 and 8: founder mutation in the UK population","volume":"20","author":"Carr","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"4","key":"10.1016\/j.gene.2023.147684_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jmg.2009.072488","article-title":"Phenotypic spectrum of MFN2 mutations in the Spanish population","volume":"47","author":"Casasnovas","year":"2010","journal-title":"J. Med. Genet."},{"issue":"17","key":"10.1016\/j.gene.2023.147684_b0130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.0b013e318217e77d","article-title":"Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT","volume":"76","author":"Cassereau","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0135","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00019052-199410000-00002","article-title":"Inherited neuropathies","volume":"7","author":"Chance","year":"1994","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0140","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/brv.12378","article-title":"Structure, function, and regulation of mitofusin-2 in health and disease","volume":"93","author":"Chandhok","year":"2018","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.200211046","article-title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development","volume":"160","author":"Chen","year":"2003","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.gene.2023.147684_b0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2007.00763.x","article-title":"Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2","volume":"71","author":"Cho","year":"2007","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0155","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cge.12432","article-title":"A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients","volume":"87","author":"Choi","year":"2015","journal-title":"Clin. Genet."},{"issue":"Pt 8","key":"10.1016\/j.gene.2023.147684_b0160","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/brain\/awl174","article-title":"Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations","volume":"129","author":"Chung","year":"2006","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.gene.2023.147684_b0165","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nmd.2008.05.012","article-title":"Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A","volume":"18","author":"Chung","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"11","key":"10.1016\/j.gene.2023.147684_b0170","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/jnnp.2009.181669","article-title":"Early-onset Charcot-Marie-Tooth patients with mitofusin 2 mutations and brain involvement","volume":"81","author":"Chung","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0404.1987.tb07882.x","article-title":"Prevalence of hereditary motor and sensory neuropathy in Cantabria","volume":"75","author":"Combarros","year":"1987","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.gene.2023.147684_b0180","first-page":"3793226","article-title":"Concomitant MPZ and MFN2 Gene Variants and Charcot Marie Tooth Disease in a Boy: Clinical and Genetic Analysis-Literature Review","volume":"2022","author":"Comella","year":"2022","journal-title":"Case Rep Pediatr."},{"issue":"24","key":"10.1016\/j.gene.2023.147684_b0185","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/01.wnl.0000327095.32005.a4","article-title":"Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction","volume":"71","author":"Del Bo","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.gene.2023.147684_b0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1083\/jcb.200611080","article-title":"Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations","volume":"176","author":"Detmer","year":"2007","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.braindev.2015.11.006","article-title":"Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation","volume":"38","author":"Di Meglio","year":"2016","journal-title":"Brain Dev."},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mgg3.106","article-title":"The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy","volume":"2","author":"DiVincenzo","year":"2014","journal-title":"Mol. Genet. Genomic Med."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jnc.14217","article-title":"Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies","volume":"143","author":"Dohrn","year":"2017","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mgg3.126","article-title":"Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing","volume":"3","author":"Drew","year":"2015","journal-title":"Mol. Genet. Genomic Med."},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/prot.340160109","article-title":"Prediction of protein folding class from amino acid composition","volume":"16","author":"Dubchak","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.gene.2023.147684_b0220","doi-asserted-by":"crossref","unstructured":"Engelfried, K., Vorgerd, M., Hagedorn, M., et al. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). BMC Med. Genet. Jun 8 2006;7:53. doi:10.1186\/1471-2350-7-53.","DOI":"10.1186\/1471-2350-7-53"},{"issue":"20","key":"10.1016\/j.gene.2023.147684_b0225","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.0b013e31821a441e","article-title":"MFN2 mutations cause severe phenotypes in most patients with CMT2A","volume":"76","author":"Feely","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0230","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jnnp-2011-300285","article-title":"Charcot-Marie-Tooth disease in Northern England","volume":"83","author":"Foley","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.122.001332","article-title":"Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A","volume":"383","author":"Franco","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.gene.2023.147684_b0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.gene.2023.147684_b0245","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00415-019-09358-1","article-title":"Multi-gene testing in neurological disorders showed an improved diagnostic yield: data from over 1000 Indian patients","volume":"266","author":"Ganapathy","year":"2019","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0250","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.nmd.2011.03.008","article-title":"Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2","volume":"21","author":"Genari","year":"2011","journal-title":"Neuromuscul. Disord."},{"issue":"7","key":"10.1016\/j.gene.2023.147684_b0255","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.celrep.2015.07.023","article-title":"Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy","volume":"12","author":"Gonzaga-Jauregui","year":"2015","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.gene.2023.147684_b0260","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/13816810.2011.587859","article-title":"Structural and functional measures of inner retinal integrity following visual acuity improvement in a patient with hereditary motor and sensory neuropathy type VI","volume":"32","author":"Gowrisankaran","year":"2011","journal-title":"Ophthalmic Genet."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WNO.0000000000000965","article-title":"Optic Neuropathy in Charcot-Marie-Tooth Disease","volume":"41","author":"Hamedani","year":"2021","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.gene.2023.147684_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/210401","article-title":"Genetic diagnosis of Charcot-Marie-Tooth disease in a population by next-generation sequencing","volume":"2014","author":"Hoyer","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"7","key":"10.1016\/j.gene.2023.147684_b0280","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7868\/S0016675813060040","article-title":"MFN2 gene analysis in patients with hereditary motor and sensory neuropathy from Bashkortostan Republic","volume":"49","author":"Khidiyatova","year":"2013","journal-title":"Genetika"},{"issue":"1\u20132","key":"10.1016\/j.gene.2023.147684_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-004-1199-2","article-title":"Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A","volume":"116","author":"Kijima","year":"2005","journal-title":"Hum. Genet."},{"issue":"11","key":"10.1016\/j.gene.2023.147684_b0290","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/jnnp-2013-306740","article-title":"Application of whole exome sequencing in undiagnosed inherited polyneuropathies","volume":"85","author":"Klein","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.gene.2023.147684_b0295","doi-asserted-by":"crossref","unstructured":"Lassuthova, P., Safka Brozkova, D., Krutova, M., et al. Improving diagnosis of inherited peripheral neuropathies through gene panel analysis. Orphanet J Rare Dis. Aug 22 2016;11(1):118. doi:10.1186\/s13023-016-0500-5.","DOI":"10.1186\/s13023-016-0500-5"},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0300","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","article-title":"Charcot-Marie-Tooth disease and related disorders: an evolving landscape","volume":"32","author":"Laura","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0305","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/01.wnl.0000168898.76071.70","article-title":"Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene","volume":"65","author":"Lawson","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.24824","article-title":"Cerebral white matter abnormalities in patients with charcot-marie-tooth disease","volume":"81","author":"Lee","year":"2017","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.gene.2023.147684_b0315","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s00415-015-7756-x","article-title":"Acute optic neuropathy associated with a novel MFN2 mutation","volume":"262","author":"Leonardi","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.gene.2023.147684_b0320","doi-asserted-by":"crossref","unstructured":"Li, Y.J., Cao, Y.L., Feng, J.X., et al. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset. Nat Commun. Oct 29 2019;10(1):4914. doi:10.1038\/s41467-019-12912-0.","DOI":"10.1038\/s41467-019-12912-0"},{"issue":"19","key":"10.1016\/j.gene.2023.147684_b0325","doi-asserted-by":"crossref","first-page":"27655","DOI":"10.18632\/oncotarget.8377","article-title":"Improving molecular diagnosis of Chinese patients with Charcot-Marie-Tooth by targeted next-generation sequencing and functional analysis","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.gene.2023.147684_b0330","doi-asserted-by":"crossref","first-page":"e29393","DOI":"10.1371\/journal.pone.0029393","article-title":"The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0335","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10072-017-2905-x","article-title":"Charcot-Marie-Tooth disease: genetic subtypes in the Sardinian population","volume":"38","author":"Lorefice","year":"2017","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0340","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jns.12299","article-title":"Genetic epidemiology, demographic, and clinical characteristics of Charcot-Marie-tooth disease in the island of Gran Canaria (Spain)","volume":"24","author":"Lousa","year":"2019","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5414\/NP300464","article-title":"Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses","volume":"32","author":"Lv","year":"2013","journal-title":"Clin. Neuropathol.. Jan-Feb"},{"issue":"1\u20132","key":"10.1016\/j.gene.2023.147684_b0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2015.08.1528","article-title":"A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A","volume":"358","author":"Lv","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0355","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s00415-023-11559-8","article-title":"A meta-analysis on the prevalence of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies","volume":"270","author":"Ma","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.gene.2023.147684_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.757518","article-title":"The Genotype and Phenotype Features in a Large Chinese MFN2 Mutation Cohort","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.nmd.2010.09.009","article-title":"Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene","volume":"21","author":"Marchesi","year":"2011","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0370","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1083\/jcb.201611194","article-title":"A new mitofusin topology places the redox-regulated C terminus in the mitochondrial intermembrane space","volume":"217","author":"Mattie","year":"2018","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.gene.2023.147684_b0375","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00415-011-5910-7","article-title":"Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2","volume":"258","author":"McCorquodale","year":"2011","journal-title":"J. Neurol."},{"issue":"18","key":"10.1016\/j.gene.2023.147684_b0380","doi-asserted-by":"crossref","first-page":"i444","DOI":"10.1093\/bioinformatics\/bts398","article-title":"Protein domain recurrence and order can enhance prediction of protein functions","volume":"28","author":"Messih","year":"2012","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.gene.2023.147684_b0385","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","article-title":"Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing","volume":"83","author":"Murphy","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0390","doi-asserted-by":"crossref","first-page":"382","DOI":"10.14348\/molcells.2016.2288","article-title":"Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing","volume":"39","author":"Nam","year":"2016","journal-title":"Mol. Cells"},{"issue":"11","key":"10.1016\/j.gene.2023.147684_b0395","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/humu.24102","article-title":"Frequency spectrum of rare and clinically relevant markers in multiethnic Indian populations (ClinIndb): A resource for genomic medicine in India","volume":"41","author":"Narang","year":"2020","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1468-1331.2006.01688.x","article-title":"Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A)","volume":"14","author":"Neusch","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"19","key":"10.1016\/j.gene.2023.147684_b0405","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/01.wnl.0000311275.89032.22","article-title":"Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations","volume":"70","author":"Nicholson","year":"2008","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.gene.2023.147684_b0410","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet. Med.: Off. J. Am. College Med. Genet."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0415","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/cge.13793","article-title":"Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies","volume":"98","author":"Padilha","year":"2020","journal-title":"Clin. Genet."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0420","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/WCO.0000000000000474","article-title":"New developments in Charcot-Marie-Tooth neuropathy and related diseases","volume":"30","author":"Pareyson","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0425","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/gim.2015.124","article-title":"The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy","volume":"18","author":"Pehlivan","year":"2016","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.gene.2023.147684_b0430","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1093\/brain\/awaa323","article-title":"Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study","volume":"143","author":"Pipis","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.gene.2023.147684_b0435","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/B978-0-444-64076-5.00042-9","article-title":"Neuropathy","volume":"148","author":"Pisciotta","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.gene.2023.147684_b0445","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.49.6.1630","article-title":"Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A","volume":"49","author":"Saito","year":"1997","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1016\/j.gene.2023.147684_b0450","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/jcs.114.5.867","article-title":"Control of mitochondrial morphology by a human mitofusin","volume":"114","author":"Santel","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.gene.2023.147684_b0455","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2014.10.005","article-title":"Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties","volume":"263","author":"Saporta","year":"2015","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot-Marie-Tooth disease subtypes and genetic testing strategies","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann. Neurol."},{"issue":"18","key":"10.1016\/j.gene.2023.147684_b0465","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10048-016-0504-2","article-title":"Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child","volume":"18","author":"Schon","year":"2017","journal-title":"Neurogenetics"},{"key":"10.1016\/j.gene.2023.147684_b0475","doi-asserted-by":"crossref","unstructured":"Sitarz, K.S., Yu-Wai-Man, P., Pyle, A., et al. MFN2 mutations cause compensatory mitochondrial DNA proliferation. Brain. Aug 2012;135(Pt 8):e219, 1-3; author reply e220, 1-3. doi:10.1093\/brain\/aws049.","DOI":"10.1093\/brain\/aws049"},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0480","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth's disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.gene.2023.147684_b0485","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1529-8027.2009.00234.x","article-title":"Ultrastructural mitochondrial modifications characteristic of mitofusin 2 mutations (CMT2A)","volume":"14","author":"Sole","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1\u20132","key":"10.1016\/j.gene.2023.147684_b0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.033","article-title":"MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives","volume":"356","author":"Stuppia","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0495","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.gim.0000200160.29385.73","article-title":"Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management","volume":"8","author":"Szigeti","year":"2006","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0500","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/cge.13967","article-title":"Molecular genetics of inherited retinal degenerations in Icelandic patients","volume":"100","author":"Thorsteinsson","year":"2021","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.gene.2023.147684_b0505","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jns.12148","article-title":"Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy","volume":"20","author":"Tufano","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"11","key":"10.1016\/j.gene.2023.147684_b0510","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/NEN.0b013e31818b6cbc","article-title":"Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations","volume":"67","author":"Vallat","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0515","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1442-200X.2012.03644.x","article-title":"Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum","volume":"54","author":"Vasta","year":"2012","journal-title":"Pediatr. Int."},{"issue":"Pt 8","key":"10.1016\/j.gene.2023.147684_b0520","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/brain\/awl126","article-title":"MFN2 mutation distribution and genotype\/phenotype correlation in Charcot-Marie-Tooth type 2","volume":"129","author":"Verhoeven","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0525","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/0970-9185.81845","article-title":"Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene","volume":"27","author":"Vinci","year":"2011","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2023.147684_b0530","doi-asserted-by":"crossref","unstructured":"Werheid, F., Azzedine, H., Zwerenz. E., et al. Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene? Brain Behav. Apr 2016;6(4):e00451. doi:10.1002\/brb3.451.","DOI":"10.1002\/brb3.451"},{"key":"10.1016\/j.gene.2023.147684_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.705277","article-title":"The Pathological Features of Common Hereditary Mitochondrial Dynamics Neuropathy","volume":"15","author":"Wu","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.gene.2023.147684_b0540","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jns.12159","article-title":"MFN2-related genetic and clinical features in a cohort of Chinese CMT2 patients","volume":"21","author":"Xie","year":"2016","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"47","key":"10.1016\/j.gene.2023.147684_b0545","first-page":"3324","article-title":"Mutation analysis of MFN2 gene in Chinese patients with Charcot-Marie-Tooth disease","volume":"89","author":"Zhang","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.gene.2023.147684_b0550","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI124194","article-title":"Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model","volume":"129","author":"Zhou","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.gene.2023.147684_b0555","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/01.wnl.0000171345.62270.29","article-title":"Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations","volume":"65","author":"Zhu","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.gene.2023.147684_b0560","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Zuchner","year":"2004","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.gene.2023.147684_b0565","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.20797","article-title":"Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2","volume":"59","author":"Zuchner","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111923005255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111923005255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T22:25:03Z","timestamp":1736375103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111923005255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":113,"alternative-id":["S0378111923005255"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2023.147684","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrative analysis of genotype-phenotype correlation in Charcot Marie Tooth type 2A disease with MFN2 variants: A case and systematic review","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2023.147684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147684"}}